Skip to main content
ResearchTreatments

Levy Lauds Biomarker-Driven Data in Lung Cancer

By June 19, 2021November 6th, 2021No Comments

*March 2021*

In this podcast, Benjamin P. Levy, MD, an associate professor of oncology and clinical director of Medical Oncology at Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, discusses exciting research with targeted therapies for patients with lung cancer who harbor molecular abberations.

Dr. Levy discusses recent advances in NTRK-, KRAS-, and HER2-altered lung cancer.

Listen to the podcast here.